# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001021771-25-000092
Filing Date
2025-06-13
Accepted
2025-06-13 08:31:05
Documents
16
Period of Report
2025-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRESENTATION - INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH | brt8k.htm iXBRL | 8-K | 27994
2 | PRESS RELEASE DATED JUNE 13, 2025 | ex99_1.htm | EX-99.1 | 27605
3 | PRESENTATION MATERIALS | ex99_2.htm | EX-99.2 | 694
7 |  | image0.jpg | GRAPHIC | 27025
8 |  | poster.jpg | GRAPHIC | 11830386
| Complete submission text file | 0001021771-25-000092.txt |  | 16513118

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | brtx-20250613.xsd | EX-101.SCH | 3883
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | brtx-20250613_lab.xml | EX-101.LAB | 21966
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | brtx-20250613_pre.xml | EX-101.PRE | 16056
18 | EXTRACTED XBRL INSTANCE DOCUMENT | brt8k_htm.xml | XML | 4031

Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 251044812
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)